Close

Press Releases

Top 6 Healthcare Innovations For 2019

Technology now plays a vital role in the healthcare sector. Anticipating industry innovations are critical to the prevention and treatment of specific ailments. Still, it's not enough to only learn about emerging technologies for the healthcare field. ...

New Clinerion And Citeline Partnership Simplifies and Strengthens Matchmaking Between Clinical Researchers and Qualified Patients

Collaboration between two companies leads to more informed decisions for clinical researchers, grounded in real-world evidence. Citeline, part of the Informa Pharma Intelligence family, and Clinerion, today announced a partnership between the two companies providing clinical...

Xellia Pharmaceuticals Receives US FDA Approval for Premixed Vancomycin Injection

Xellia Pharmaceuticals , a global leader in the manufacturing of specialty anti-infective treatments, announced t has received U.S. FDA approval for Premixed Vancomycin Injection in a Ready-to-Use (RTU) bag in the United States market. This approval...

West and Swissfillon to Partner on an Integrated Solution for Clinical Filling of SmartDoseยฎ Drug Delivery Platform

West is pleased to announce that it has commenced discussions with Swissfillon AG, a provider of aseptic fill and finish services to pharmaceutical and biotechnology companies. That are intended to lead to a non-exclusive global collaboration...

Glatt launches phosphorus recovery system and compact fluidised bed agglomeration solution

At POWTECH 2019 in Nuremberg, the plant manufacturing and process development specialist, Glatt, is presenting a groundbreaking waste-free process that recycles the phosphorus from ash to produce ready-to-use high-quality fertilisers. The second highlight is a new...

Sharp Announces $650K Investment to Enhances IRT Solution

Sharp has announced a $650,000 investment into enhancing its Interactive Response Technology (IRT) solution. Sharpโ€™s IRT solution is used to manage patient interactions and drug supplies during clinical trials and perform a range of functions for sponsors, drug depots...

EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with CD30+ Stage IV Hodgkin Lymphoma

Takeda Pharmaceutical Co. announced that the EC extended the current marketing authorization of ADCETRIS to include treatment of adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma in combination with AVD (Adriamycin, vinblastine and dacarbazine). ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป